Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-01-2023 | Vasculitis | Case report

Elasomeran

Central retinal artery occlusion, central retinal vein occlusion and retinal vasculitis: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Ikegami Y, et al. Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination. QJM - An International Journal of Medicine 114 : 884-885, No. 12, Dec 2021. Available from: URL: http://qjmed.oxfordjournals.org/ Ikegami Y, et al. Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination. QJM - An International Journal of Medicine 114 : 884-885, No. 12, Dec 2021. Available from: URL: http://​qjmed.​oxfordjournals.​org/​
Metadata
Title
Elasomeran
Central retinal artery occlusion, central retinal vein occlusion and retinal vasculitis: case report
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-31599-4

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Venlafaxine

Case report

Pembrolizumab

Case report

Lamotrigine